I’m very happy to announce that we have received good news from the Dutch Cancer Society. The project: ‘POINTING: Towards patient-tailored cancer immunotherapy supported by a multifaceted predictive signature composed of integrative omics and molecular imaging’ will receive funding from the ‘PROGRAMME RESEARCH & IMPLEMENTATION CALL 2016-I’. As one of the four principal investigators on this project I am looking forward to start this project in collaboration with Liesbeth de Vries, John Haanen and Ronald Boellaard.